Relugolix in Combination With Radiation Therapy for Treating Patients With High Risk Prostate Cancer

Clinical trial NCT06129851 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06129851
Sponsor: University of Kansas Medical Center
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Stage IIC Prostate Cancer AJCC v8 Stage III Prostate Cancer AJCC v8 Stage IV Prostate Cancer AJCC v8

Start date: 2023-11-20
Primary completion: 2025-10-23
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.